Request a FREE Sample of our FcRn Binding Kit!Request a FREE Sample of our Fc gamma RI / CD64 Binding Kit !
Happy Holiday! Limited Keychain here with your next orderHappy Holiday! Limited Keychain here with your next order
Request a FREE sample of our GMP products! Request a FREE sample of our GMP products!
Expression analysis of human uPAR on HEK293/Human uPAR Stable Cell Line by FACS.
Cell surface staining was performed on HEK293/Human uPAR Stable Cell Line or negative control cell using PE-labeled anti-human uPAR antibody.
Expression analysis of human uPAR on CHO/Human uPAR Stable Cell Line by FACS.
Cell surface staining was performed on CHO/Human uPAR Stable Cell Line or negative control cell using PE-labeled anti-human uPAR antibody.
Human PLAU, His Tag (Cat. No. PLU-H5229) capture on NTA-Series S sensor chip can bind Mouse uPAR Protein, Fc Tag (Cat. No. UPR-M5253) with an affinity constant of 182 nM as determined in a SPR assay (Biacore 8K) (QC tested).
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
FG-001 | FG001; FG-001 | Phase 2 Clinical | FluoGuide AS | Head and Neck Neoplasms; Brain Neoplasms; Glioma; Lung Neoplasms; Meningioma | Details |
Gallium-68 NOTA AE105 (Curasight) | CS-001; 68Ga-NOTA-AE105 | Phase 2 Clinical | Rigshospitalet, Curasight Aps | Bone metastases; Head and Neck Neoplasms; Neoplasms; Glioblastoma; Urinary Bladder Neoplasms; Neuroendocrine Tumors; Mesothelioma; Prostatic Neoplasms; Breast Neoplasms; Oropharyngeal Neoplasms; Genital Neoplasms, Female; Mouth Neoplasms; Carcinoma, Non-Small-Cell Lung | Details |
WAL-0921 | WAL0921; WAL-0921 | Phase 1 Clinical | Walden Biosciences Inc | Renal Insufficiency, Chronic | Details |
MNPR-101-Zr | MNPR-101-Zr; MNPR-101-DFO*-89Zr | Phase 1 Clinical | Monopar Therapeutics Inc, Northstar Medical Radioisotopes Llc | Ovarian Neoplasms; Solid tumours; Stomach Neoplasms; Pancreatic Neoplasms; Triple Negative Breast Neoplasms; Neoplasms; Small Cell Lung Carcinoma; Carcinoma, Transitional Cell; Urinary Bladder Neoplasms; Colorectal Neoplasms; Lung Neoplasms | Details |
KMHH-03 | KMHH-03; KMHH03 | Phase 1 Clinical | Beijing Kangming Haihui Biological Technology Co Ltd | Breast Neoplasms | Details |
FG-001 | FG001; FG-001 | Phase 2 Clinical | FluoGuide AS | Head and Neck Neoplasms; Brain Neoplasms; Glioma; Lung Neoplasms; Meningioma | Details |
Gallium-68 NOTA AE105 (Curasight) | CS-001; 68Ga-NOTA-AE105 | Phase 2 Clinical | Rigshospitalet, Curasight Aps | Bone metastases; Head and Neck Neoplasms; Neoplasms; Glioblastoma; Urinary Bladder Neoplasms; Neuroendocrine Tumors; Mesothelioma; Prostatic Neoplasms; Breast Neoplasms; Oropharyngeal Neoplasms; Genital Neoplasms, Female; Mouth Neoplasms; Carcinoma, Non-Small-Cell Lung | Details |
WAL-0921 | WAL0921; WAL-0921 | Phase 1 Clinical | Walden Biosciences Inc | Renal Insufficiency, Chronic | Details |
MNPR-101-Zr | MNPR-101-Zr; MNPR-101-DFO*-89Zr | Phase 1 Clinical | Monopar Therapeutics Inc, Northstar Medical Radioisotopes Llc | Ovarian Neoplasms; Solid tumours; Stomach Neoplasms; Pancreatic Neoplasms; Triple Negative Breast Neoplasms; Neoplasms; Small Cell Lung Carcinoma; Carcinoma, Transitional Cell; Urinary Bladder Neoplasms; Colorectal Neoplasms; Lung Neoplasms | Details |
KMHH-03 | KMHH-03; KMHH03 | Phase 1 Clinical | Beijing Kangming Haihui Biological Technology Co Ltd | Breast Neoplasms | Details |
This web search service is supported by Google Inc.